Cargando…

Pathogenic PS1 phosphorylation at Ser367

The high levels of serine (S) and threonine (T) residues within the Presenilin 1 (PS1) N-terminus and in the large hydrophilic loop region suggest that the enzymatic function of PS1/γ-secretase can be modulated by its ‘phosphorylated’ and ‘dephosphorylated’ states. However, the functional outcome of...

Descripción completa

Detalles Bibliográficos
Autores principales: Maesako, Masato, Horlacher, Jana, Zoltowska, Katarzyna M, Kastanenka, Ksenia V, Kara, Eleanna, Svirsky, Sarah, Keller, Laura J, Li, Xuejing, Hyman, Bradley T, Bacskai, Brian J, Berezovska, Oksana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279945/
https://www.ncbi.nlm.nih.gov/pubmed/28132667
http://dx.doi.org/10.7554/eLife.19720
_version_ 1782502868210679808
author Maesako, Masato
Horlacher, Jana
Zoltowska, Katarzyna M
Kastanenka, Ksenia V
Kara, Eleanna
Svirsky, Sarah
Keller, Laura J
Li, Xuejing
Hyman, Bradley T
Bacskai, Brian J
Berezovska, Oksana
author_facet Maesako, Masato
Horlacher, Jana
Zoltowska, Katarzyna M
Kastanenka, Ksenia V
Kara, Eleanna
Svirsky, Sarah
Keller, Laura J
Li, Xuejing
Hyman, Bradley T
Bacskai, Brian J
Berezovska, Oksana
author_sort Maesako, Masato
collection PubMed
description The high levels of serine (S) and threonine (T) residues within the Presenilin 1 (PS1) N-terminus and in the large hydrophilic loop region suggest that the enzymatic function of PS1/γ-secretase can be modulated by its ‘phosphorylated’ and ‘dephosphorylated’ states. However, the functional outcome of PS1 phosphorylation and its significance for Alzheimer’s disease (AD) pathogenesis is poorly understood. Here, comprehensive analysis using FRET-based imaging reveals that activity-driven and Protein Kinase A-mediated PS1 phosphorylation at three domains (domain 1: T74, domain 2: S310 and S313, domain 3: S365, S366, and S367), with S367 being critical, is responsible for the PS1 pathogenic ‘closed’ conformation, and resulting increase in the Aβ42/40 ratio. Moreover, we have established novel imaging assays for monitoring PS1 conformation in vivo, and report that PS1 phosphorylation induces the pathogenic conformational shift in the living mouse brain. These phosphorylation sites represent potential new targets for AD treatment. DOI: http://dx.doi.org/10.7554/eLife.19720.001
format Online
Article
Text
id pubmed-5279945
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-52799452017-02-01 Pathogenic PS1 phosphorylation at Ser367 Maesako, Masato Horlacher, Jana Zoltowska, Katarzyna M Kastanenka, Ksenia V Kara, Eleanna Svirsky, Sarah Keller, Laura J Li, Xuejing Hyman, Bradley T Bacskai, Brian J Berezovska, Oksana eLife Biochemistry The high levels of serine (S) and threonine (T) residues within the Presenilin 1 (PS1) N-terminus and in the large hydrophilic loop region suggest that the enzymatic function of PS1/γ-secretase can be modulated by its ‘phosphorylated’ and ‘dephosphorylated’ states. However, the functional outcome of PS1 phosphorylation and its significance for Alzheimer’s disease (AD) pathogenesis is poorly understood. Here, comprehensive analysis using FRET-based imaging reveals that activity-driven and Protein Kinase A-mediated PS1 phosphorylation at three domains (domain 1: T74, domain 2: S310 and S313, domain 3: S365, S366, and S367), with S367 being critical, is responsible for the PS1 pathogenic ‘closed’ conformation, and resulting increase in the Aβ42/40 ratio. Moreover, we have established novel imaging assays for monitoring PS1 conformation in vivo, and report that PS1 phosphorylation induces the pathogenic conformational shift in the living mouse brain. These phosphorylation sites represent potential new targets for AD treatment. DOI: http://dx.doi.org/10.7554/eLife.19720.001 eLife Sciences Publications, Ltd 2017-01-30 /pmc/articles/PMC5279945/ /pubmed/28132667 http://dx.doi.org/10.7554/eLife.19720 Text en © 2017, Maesako et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Biochemistry
Maesako, Masato
Horlacher, Jana
Zoltowska, Katarzyna M
Kastanenka, Ksenia V
Kara, Eleanna
Svirsky, Sarah
Keller, Laura J
Li, Xuejing
Hyman, Bradley T
Bacskai, Brian J
Berezovska, Oksana
Pathogenic PS1 phosphorylation at Ser367
title Pathogenic PS1 phosphorylation at Ser367
title_full Pathogenic PS1 phosphorylation at Ser367
title_fullStr Pathogenic PS1 phosphorylation at Ser367
title_full_unstemmed Pathogenic PS1 phosphorylation at Ser367
title_short Pathogenic PS1 phosphorylation at Ser367
title_sort pathogenic ps1 phosphorylation at ser367
topic Biochemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279945/
https://www.ncbi.nlm.nih.gov/pubmed/28132667
http://dx.doi.org/10.7554/eLife.19720
work_keys_str_mv AT maesakomasato pathogenicps1phosphorylationatser367
AT horlacherjana pathogenicps1phosphorylationatser367
AT zoltowskakatarzynam pathogenicps1phosphorylationatser367
AT kastanenkakseniav pathogenicps1phosphorylationatser367
AT karaeleanna pathogenicps1phosphorylationatser367
AT svirskysarah pathogenicps1phosphorylationatser367
AT kellerlauraj pathogenicps1phosphorylationatser367
AT lixuejing pathogenicps1phosphorylationatser367
AT hymanbradleyt pathogenicps1phosphorylationatser367
AT bacskaibrianj pathogenicps1phosphorylationatser367
AT berezovskaoksana pathogenicps1phosphorylationatser367